NCT00418847
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +18 more
- Locations
-
- The Hospital for Sick Children Toronto, Ontario, Canada
Clinical trial condition
Tay-Sachs Disease
Explore clinical trials studying Tay-Sachs Disease. Study availability and eligibility vary by location and protocol.
16 public trials
3 recruiting studies
Tay-Sachs Disease trial results
Completed
Gene Therapy for Tay-Sachs Disease
NCT01869270
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Data Management and Coordinating Center (DMCC), Univ. of South Florida Tampa, Florida, United States
- University of Minnesota Minneapolis, Minnesota, United States
Completed
Pyrimethamine as a Treatment for Late-Onset GM2-gangliosidosis (Tay-Sachs and Sandhoff Disease)
NCT01102686
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +17 more
- Locations
-
- The Hospital for Sick Children Toronto, Ontario, Canada
NCT00006057
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +25 more
- Locations
-
- Mount Sinai School of Medicine New York, United States
Active, Not Recruiting
Long-Term Follow-Up of Subjects Treated With AXO-AAV-GM2 for Tay-Sachs or Sandhoff Disease
NCT06614569
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- UMass Chan Medical School Worcester, Massachusetts, United States
Active, Not Recruiting
First-in-Human Study of TSHA-101 Gene Therapy for Treatment of Infantile Onset GM2 Gangliosidosis
NCT04798235
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +18 more
- Locations
-
- Queen's University/Kingston Health Sciences Centre Kingston, Ontario, Canada